A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

Novel myostatin-specific antibody enhances muscle strength in muscle disease models

(2021) Hiroyasu Muramatsu et al.   Scientific Reports

CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model

(2019) Vinh Thi Ha Nguyen et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

CD22 and CD72 contribute to the development of scleroderma in a murine model

(2019) Chunyan Zhao et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

(2018) Takashi Matsushita et al.   Science Advances

Regulatory and effector B cells: Friends or foes?

(2018) Takashi Matsushita   JOURNAL OF DERMATOLOGICAL SCIENCE

Systemic sclerosis

(2017) Yoshihide Asano   JOURNAL OF DERMATOLOGY

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

(2016) Dinesh Khanna et al.   LANCET

Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131

(2013) F. Mimoto et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Potential roles of interleukin-17A in the development of skin fibrosis in mice

(2012) Yoshinobu Okamoto et al.   ARTHRITIS AND RHEUMATISM

Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?

(2010) T. C. Barnes et al.   ANNALS OF THE RHEUMATIC DISEASES

Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway

(2010) Chihiro Tanaka et al.   ARTHRITIS AND RHEUMATISM

The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis

(2008) Y. Hamaguchi et al.   BRITISH JOURNAL OF DERMATOLOGY